Richard J Salute

NewtekOne director Richard J. Salute makes open-market purchase of 1,000 shares, extending a consistent buying pattern with no prior sales on record.

Richard J. Salute, a director at NewtekOne, made a modest open-market purchase that adds to an extensive history of buying — he has made 14 prior open-market purchases with zero open-market sales on record. The stock is trading well off its fifty-two-week lows and has rallied strongly over the past month, placing Salute's purchase near the higher end of its recent range but still meaningfully below the year's peak. NewtekOne is a profitable company trading at what appears to be a low valuation multiple relative to its earnings, which provides some fundamental backdrop for the purchase. Salute's prior buys in this stock have shown a conflicting pattern across time horizons: every one of the five tracked prior purchases was followed by a stock gain in the near term, but outcomes over the longer ninety-day window were more mixed, with roughly half seeing positive and half seeing negative results. This is a routine-sized addition to his position, and while Salute's near-term track record has been uniformly positive in prior instances, the modest scale and absence of any cluster of insider activity make this a relatively low-urgency signal on its own.

Director Salute buys 900 shares at $11.28; 30-day momentum +10.2% but 90-day return -2.9% mirrors mixed track record across NEWT holdings.

Richard J. Salute, a Director at NewtekOne, purchased 900 shares at $11.28 on 2025-12-08, increasing his holdings to 44,505 shares—a 2.1% net addition to his existing stake. The current price of $11.32 sits 20.6% below the 52-week high of $14.25, though the 30-day price momentum is +10.2%, reflecting a recent partial recovery; the 90-day return, however, is -2.9%. Across Salute's five prior trades at NEWT, a mixed pattern emerges: three of the five buys achieved positive 90-day returns (50% well-timed rate), suggesting modest timing acumen at this specific ticker. Set against his broader cross-ticker track record showing an average 90-day return of -5.6% and a 30.77% win rate, the current purchase enters a context of below-average historical execution. Fundamentally, NEWT trades at a P/E of 5.52 with recent quarterly revenue of $38,166,000.00 and net income of $17,901,000.00; the low valuation multiple and strong profitability metrics have not prevented the stock from trailing its 52-week highs.

Director Salute buys 2,100 NEWT shares at blended $11.24; stock currently $11.37, down 26.5% from 52-week high

Director Richard J Salute purchased 2,100 shares across 2 transactions on 2025-08-01 at a blended average price of $11.24, increasing his holdings from 41,505 to 43,605 shares (+5.1%). The stock currently trades at $11.37, modestly above the purchase price, and sits near the lower end of its 52-week range ($9.54–$15.46), having declined 26.5% from its 52-week high and 6.4% over the past month. At NEWT specifically, Salute's prior trade on 2024-09-20 achieved a 90-day return of +7.5%, though his more recent May 2025 purchases show near-flat 30-day performance and his December 2024 buy declined 3.8% over 90 days. The company's P/E of 5.92 and net income of $9.4M on revenue of $38.2M suggest modest profitability relative to valuation, providing limited context for whether this purchase represents opportunistic accumulation or routine portfolio management at a depressed price.

Director Richard J. Salute buys 5,000 shares for $55,338.12 at NEWT; cluster pattern with 3 other insiders in 14 days

Richard J. Salute, a Director at NewtekOne, executed 3 separate purchases totaling 5,000 shares for $55,338.12 at a blended average price of $11.07 on 2025-05-12, raising his holdings by 14.6% from 34,222 to 39,222 shares. The current price of $11.57 is 25.2% below the 52-week high, and the stock has risen 15.2% over the past 30 days but declined 7.4% over 90 days. Notably, a CLUSTER of 3 other insiders also bought within the past 14 days, suggesting concurrent insider accumulation at this price level. However, Salute's prior trades at NEWT show a timing pattern of only 1 of 5 prior buys being well-timed at the 90-day mark, and his cross-ticker track record shows a 90-day win rate of 12.50% with an average 90-day return of -8.9%, indicating a mixed record of execution.

Director SALUTE RICHARD J bought 1,000 shares at $12.82 on 2024-12-23 amid cluster of 4 other insider purchases in 14 days.

Director SALUTE RICHARD J purchased 1,000 shares of NEWT at $12.82 on 2024-12-23, increasing his holdings from 33,117 to 34,117 shares. The transaction coincides with a cluster pattern in which 4 other insiders also bought within the past 14 days, suggesting coordinated interest in the security. However, the insider's cross-ticker track record shows 7 prior buys with an average 90-day return of -9.6% and a 14.29% win rate, indicating historically poor timing across his buy activity. At NEWT specifically, his prior 5 buys show mixed outcomes: only 1 of 5 achieved positive 90-day returns. The stock currently trades at $12.99, just 0.13% above the transaction price, while remaining -16.0% from its 52-week high. The company's low P/E of 6.66 on $38.2M quarterly revenue and $11.9M net income provides fundamental context for the purchase, though the cluster activity and weak prior track record limit the signal strength.

Director Salute Richard J buys 500 NEWT shares at $11.73; stock down -7.4% in 30 days. Cluster signal: 3 other insiders also bought in past 14 days.

Richard J Salute (Director) purchased 500 shares at $11.73 on 2024-09-20, adding to a position that now stands at 33,117 shares, while the stock has declined -7.4% over 30 days and trades 25% below its 52-week high of $15.82. His prior five buys at NewtekOne show a consistent pattern: 0 of 5 prior purchases generated positive 90-day returns, with an average 90-day outcome of -11.8%, suggesting poor timing at this ticker historically. However, this transaction coincides with a cluster pattern in which 3 other insiders also purchased within the past 14 days, which may signal coordinated conviction at current levels, though the company's fundamentals remain stable with a P/E of 6.25, net income of $10,945,000.00, and revenue of $38,166,000.00. The persistence of insider buying despite recent stock weakness and the director's established record of ill-timed purchases at this ticker warrant observation of whether this represents a genuine inflection point or continuation of the prior pattern.

Director Richard J Salute bought 700 NEWT shares at $12.62; stock now $12.59, down 34.6% from 52-week high, with cluster of 3 other insider buys in 14 days.

Director Richard J Salute purchased 700 shares of NewtekOne at $12.62 on 2024-06-18, increasing his holdings to 32,617 shares (+2.2%). The stock currently trades at $12.59, essentially at the transaction price but -34.6% from its 52-week high of $19.24, suggesting material recent weakness. Notably, 3 other insiders also bought within the past 14 days, forming a cluster pattern. However, the director's prior 5 trades at NEWT show a concerning 0% well-timed rate at the 90-day mark: 4 purchases in September 2023 each declined 13–20% in the following 30 days, and his November 2023 buy recovered +10.8% at 30 days but still fell 11.9% by day 90. The company maintains solid fundamentals (P/E 6.88, net income $9.6M on $38.2M revenue) but the pattern of repeated poorly-timed purchases at this ticker—combined with the stock's sharp 34.6% decline from recent highs—suggests the cluster buy may reflect price weakness rather than a validated timing signal.